Treceți offline cu aplicația Player FM !
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
Manage episode 402284859 series 3389426
touchTALKS for touchONCOLOGY
Listen to a leading expert in lung cancer discuss the role of antibody–drug conjugates (ADCs) in the treatment of patients with advanced non-small cell lung cancer, including their structure and mechanistic rationale, the latest clinical trial data and the optimal management of patients receiving ADCs.
The expert
- Dr Rebecca Heist – Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca and is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
102 episoade
Manage episode 402284859 series 3389426
touchTALKS for touchONCOLOGY
Listen to a leading expert in lung cancer discuss the role of antibody–drug conjugates (ADCs) in the treatment of patients with advanced non-small cell lung cancer, including their structure and mechanistic rationale, the latest clinical trial data and the optimal management of patients receiving ADCs.
The expert
- Dr Rebecca Heist – Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca and is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
102 episoade
Усі епізоди
×Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.